Brief: Stayble Therapeutics Q2 EBIT Loss Narrows To SEK 3.4 Mln
20/08/2024 07:16
Aug 20 (Reuters) - Stayble Therapeutics AB STABL.ST :
* Q2 EBIT LOSS SEK 3.4 MILLION VERSUS LOSS SEK 6.9 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr18yvtS
Further company coverage: STABL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln